Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-28 Purchase |
2021-06-30 5:59 pm |
Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Direct) |
View |
| 2021-06-28 Purchase |
2021-06-30 5:05 pm |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 5:00 pm |
Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
157,895 | $19 | $3,000,005 | 8,897,053 (Indirect Direct) |
View |
| 2021-06-28 Purchase |
2021-06-30 4:08 pm |
Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
600,000 | $19 | $11,400,000 | 3,202,200 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-28 Conversion |
2021-06-30 5:59 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner |
30,092,935 | $0 | 7,692,298 (Direct) |
View |
| 2021-06-28 Conversion |
2021-06-30 5:05 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
38,309,520 | $0 | 2,097,938 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 5:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
38,309,520 | $0 | 8,897,053 (Direct) |
View |
| 2021-06-28 Conversion |
2021-06-30 4:08 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
5,204,400 | $0 | 3,202,200 (Indirect) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:47 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
47,132 | $0 | 47,132 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:01 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer |
157,587 | $0 | 157,587 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:01 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Leo Chandra P. Director |
47,132 | $0 | 47,132 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:01 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
47,132 | $0 | 47,132 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:01 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director |
54,213 | $0 | 54,213 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:00 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
54,213 | $0 | 54,213 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:00 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus See Remarks |
680,140 | $0 | 680,140 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:00 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
500,367 | $0 | 500,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:00 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer |
387,069 | $0 | 387,069 (Direct) |
View |
| 2021-02-24 Option Award |
2021-06-25 5:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
3,575,000 | $2 | 9,896,460 (Indirect) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:00 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
47,132 | $0 | 9,896,460 (Direct) |
View |
| 2021-03-11 Option Award |
2021-06-25 5:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
2,699,328 | $2.9637 | 9,896,460 (Indirect) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:00 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director |
47,132 | $0 | 47,132 (Direct) |
View |
Ownership |
2021-06-23 9:15 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:14 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:14 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:12 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:12 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:10 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:09 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:08 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:07 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:05 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:03 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:01 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
Ownership |
2021-06-23 9:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner |
0 | $0 | 6,642,298 (Direct) |
View |
Ownership |
2021-06-23 8:54 pm |
N/A 2030-12-01 |
Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director |
0 | $0 | 35,931 (Direct) |
View |
Ownership |
2021-06-23 8:50 pm |
N/A 2030-12-04 |
Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer |
0 | $0 | 445,129 (Direct) |
View |
Ownership |
2021-06-23 8:47 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
0 | $0 | 8,739,158 (Indirect) |
View |
Ownership |
2021-06-23 8:44 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist |
0 | $0 | 251,594 (Direct) |
View |
Ownership |
2021-06-23 8:40 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
0 | $0 | 35,931 (Direct) |
View |
Ownership |
2021-06-23 8:38 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus See Remarks |
0 | $0 | 1,741,811 (Direct) |
View |
Ownership |
2021-06-23 8:35 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
0 | $0 | 387,069 (Direct) |
View |
Ownership |
2021-06-23 8:32 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
0 | $0 | 290,301 (Direct) |
View |